AAAAAA

   
Results: 1-25 | 26-46
Results: 1-25/46
BASIC FIBROBLAST GROWTH-FACTOR (BFGF) IN A MODEL OF USE-DEPENDENT EXAGGERATION OF BRAIN INJURY
Authors: GOTTS JE SCHALLERT T COCKE RR FINKLESTEIN SP KAWAMATA T HUMM JL
Citation: Je. Gotts et al., BASIC FIBROBLAST GROWTH-FACTOR (BFGF) IN A MODEL OF USE-DEPENDENT EXAGGERATION OF BRAIN INJURY, Journal of investigative medicine, 46(1), 1998, pp. 124-124
ELECTRON WEDGES FOR RADIATION-THERAPY
Authors: LIEF EP LO YC HUMM JL
Citation: Ep. Lief et al., ELECTRON WEDGES FOR RADIATION-THERAPY, International journal of radiation oncology, biology, physics, 40(1), 1998, pp. 233-243
RADIOIMMUNOTHERAPY WITH ALPHA-EMITTING NUCLIDES
Authors: MCDEVITT MR SGOUROS G FINN RD HUMM JL JURCIC JG LARSON SM SCHEINBERG DA
Citation: Mr. Mcdevitt et al., RADIOIMMUNOTHERAPY WITH ALPHA-EMITTING NUCLIDES, European journal of nuclear medicine, 25(9), 1998, pp. 1341-1351
IMAGING OF TRACER AMOUNTS OF I-124 IN THE PRESENCE OF THERAPEUTIC AMOUNTS OF I-131 WITH A STANDARD PET SCANNER
Authors: PENTLOW KS MAWLAWI O DAGHIGHIAN F FINN RD HUMM JL LARSON SM
Citation: Ks. Pentlow et al., IMAGING OF TRACER AMOUNTS OF I-124 IN THE PRESENCE OF THERAPEUTIC AMOUNTS OF I-131 WITH A STANDARD PET SCANNER, The Journal of nuclear medicine, 39(5), 1998, pp. 195-195
DIFFERENTIAL METABOLISM AND PHARMACOKINETICS OF C-11 METHIONINE (C-11-MET) AND FDG IN METASTATIC PROSTATE-CANCER
Authors: MACAPINLAC HA HUMM JL LARSON SM AKHURST T SQUIRE OD PENTLOW K YEUNG HWD FINN RD CAI S OSMAN I SCHER H
Citation: Ha. Macapinlac et al., DIFFERENTIAL METABOLISM AND PHARMACOKINETICS OF C-11 METHIONINE (C-11-MET) AND FDG IN METASTATIC PROSTATE-CANCER, The Journal of nuclear medicine, 39(5), 1998, pp. 258-258
PHANTOM MEASUREMENTS TO INVESTIGATE THE USE OF YTTRIUM-86 AND PET TO DETERMINE THE IN-VIVO DISTRIBUTION OF YTTRIUIM-90 LABELED PHARMACEUTICALS
Authors: PENTLOW KS FINN RD LARSON SM ERDI YE HUMM JL
Citation: Ks. Pentlow et al., PHANTOM MEASUREMENTS TO INVESTIGATE THE USE OF YTTRIUM-86 AND PET TO DETERMINE THE IN-VIVO DISTRIBUTION OF YTTRIUIM-90 LABELED PHARMACEUTICALS, The Journal of nuclear medicine, 39(5), 1998, pp. 791-791
RADIOIODINE UPTAKE IN THYROID REMNANTS DURING THERAPY FOLLOWING TRACER DOSIMETRY
Authors: YEUNG HWD HUMM JL LARSON SM
Citation: Hwd. Yeung et al., RADIOIODINE UPTAKE IN THYROID REMNANTS DURING THERAPY FOLLOWING TRACER DOSIMETRY, The Journal of nuclear medicine, 39(5), 1998, pp. 848-848
NORMAL ORGAN DOSIMETRY OF LEUKEMIA PATIENTS TREATED WITH HUM195 LABELED WITH THE ALPHA-PARTICLE EMITTER BI-213
Authors: BALLANGRUD AM HUMM JL MCDEVITT MR FINN RD JURCIC JG LARSON SM SCHEINBERG DA SGOUROS G
Citation: Am. Ballangrud et al., NORMAL ORGAN DOSIMETRY OF LEUKEMIA PATIENTS TREATED WITH HUM195 LABELED WITH THE ALPHA-PARTICLE EMITTER BI-213, The Journal of nuclear medicine, 39(5), 1998, pp. 849-849
WORLDWIDE THYROID DOSIMETRY BY INTERNET USING MEMORIAL SLOAN-KETTERING TREATMENT PROTOCOL
Authors: ERDI YE KALAIGIAN H LARSON SM HUMM JL
Citation: Ye. Erdi et al., WORLDWIDE THYROID DOSIMETRY BY INTERNET USING MEMORIAL SLOAN-KETTERING TREATMENT PROTOCOL, The Journal of nuclear medicine, 39(5), 1998, pp. 1313-1313
PHARMACOKINETIC MODEL OF IODINE-131-G250 ANTIBODY IN RENAL-CELL CARCINOMA PATIENTS
Authors: LOH A SGOUROS G ODONOGHUE JA DELAND D PURI D CAPITELLI P HUMM JL LARSON SM OLD LJ DIVGI CR
Citation: A. Loh et al., PHARMACOKINETIC MODEL OF IODINE-131-G250 ANTIBODY IN RENAL-CELL CARCINOMA PATIENTS, The Journal of nuclear medicine, 39(3), 1998, pp. 484-489
USE-DEPENDENT EXACERBATION OF BRAIN-DAMAGE OCCURS DURING AN EARLY POSTLESION VULNERABLE PERIOD
Authors: HUMM JL KOZLOWSKI DA JAMES DC GOTTS JE SCHALLERT T
Citation: Jl. Humm et al., USE-DEPENDENT EXACERBATION OF BRAIN-DAMAGE OCCURS DURING AN EARLY POSTLESION VULNERABLE PERIOD, Brain research, 783(2), 1998, pp. 286-292
DISTRIBUTION OF RADIOLABELED MONOCLONAL-ANTIBODY MX35 F(AB')2 IN TISSUE SAMPLES BY STORAGE PHOSPHOR SCREEN IMAGE-ANALYSIS - EVALUATION OF ANTIBODY LOCALIZATION TO MICROMETASTATIC DISEASE IN EPITHELIAL OVARIAN-CANCER
Authors: FINSTAD CL LLOYD KO FEDERICI MG DIVGI C VENKATRAMAN E BARAKAT RR FINN RD LARSON SM HOSKINS WJ HUMM JL
Citation: Cl. Finstad et al., DISTRIBUTION OF RADIOLABELED MONOCLONAL-ANTIBODY MX35 F(AB')2 IN TISSUE SAMPLES BY STORAGE PHOSPHOR SCREEN IMAGE-ANALYSIS - EVALUATION OF ANTIBODY LOCALIZATION TO MICROMETASTATIC DISEASE IN EPITHELIAL OVARIAN-CANCER, Clinical cancer research, 3(8), 1997, pp. 1433-1442
PREOPTIC AREA INFUSIONS OF MORPHINE DISRUPT - AND NALOXONE RESTORES -PARENTAL-LIKE BEHAVIOR IN JUVENILE RATS
Authors: WELLMAN J CARR D GRAHAM A JONES H HUMM JL RUSCIO M BILLACK B KINSLEY CH
Citation: J. Wellman et al., PREOPTIC AREA INFUSIONS OF MORPHINE DISRUPT - AND NALOXONE RESTORES -PARENTAL-LIKE BEHAVIOR IN JUVENILE RATS, Brain research bulletin, 44(2), 1997, pp. 183-191
QUANTITATIVE BONE METASTASES ANALYSIS BASED ON IMAGE SEGMENTATION
Authors: ERDI YE HUMM JL IMBRIACO M YEUNG H LARSON SM
Citation: Ye. Erdi et al., QUANTITATIVE BONE METASTASES ANALYSIS BASED ON IMAGE SEGMENTATION, The Journal of nuclear medicine, 38(9), 1997, pp. 1401-1406
COMPARISON OF THE EFFECTIVENESS OF RADIOIMMUNOTHERAPY AND FRACTIONATED RADIOTHERAPY
Authors: BARENDSWAARD EC ODONOGHUE JA LARSON SM TSCHMELITSCH J WELT S SCHLOM J SCOTT A HUMM JL
Citation: Ec. Barendswaard et al., COMPARISON OF THE EFFECTIVENESS OF RADIOIMMUNOTHERAPY AND FRACTIONATED RADIOTHERAPY, The Journal of nuclear medicine, 38(5), 1997, pp. 212-212
LIMITS OF DETECTABILITY IN THYROID-CARCINOMA - A COMPARATIVE-STUDY OFTC-99M, I-131, AND F-18
Authors: ERDI YE HUMM JL IMBRIACO M LARSON SM
Citation: Ye. Erdi et al., LIMITS OF DETECTABILITY IN THYROID-CARCINOMA - A COMPARATIVE-STUDY OFTC-99M, I-131, AND F-18, The Journal of nuclear medicine, 38(5), 1997, pp. 288-288
THE DESIGN OF A RAPID FRACTIONATION TREATMENT PROTOCOL FOR RADIOIMMUNOTHERAPY
Authors: ODONOGHUE JA SGOUROS G LOH AC DIVGI CR HUMM JL
Citation: Ja. Odonoghue et al., THE DESIGN OF A RAPID FRACTIONATION TREATMENT PROTOCOL FOR RADIOIMMUNOTHERAPY, The Journal of nuclear medicine, 38(5), 1997, pp. 442-442
G250 ANTIBODY PHARMACOKINETIC PARAMETERS FOR A MODEL OF TUMOR RESPONSE IN RADIOIMMUNOTHERAPY
Authors: SGOUROS G LOH AC ODONOGHUE JA DELAND D PURI D CAPITELLI P HUMM JL LARSON SM OLD LJ DIVGI CR
Citation: G. Sgouros et al., G250 ANTIBODY PHARMACOKINETIC PARAMETERS FOR A MODEL OF TUMOR RESPONSE IN RADIOIMMUNOTHERAPY, The Journal of nuclear medicine, 38(5), 1997, pp. 975-975
THE USE OF PHOSPHOR PLATES FOR QUANTITATIVE-ANALYSIS OF RADIOLABELED MONOCLONAL-ANTIBODY LOCALIZATION
Authors: HUMM JL FEDERICI M FINSTAD CL LLOYD K LARSON S HOSKINS W DIVGI C
Citation: Jl. Humm et al., THE USE OF PHOSPHOR PLATES FOR QUANTITATIVE-ANALYSIS OF RADIOLABELED MONOCLONAL-ANTIBODY LOCALIZATION, The Journal of nuclear medicine, 38(5), 1997, pp. 976-976
RADIATION-DOSE TO THE SALIVARY-GLANDS DURING I-131 TREATMENT OF THYROID-CANCER - CORRELATION WITH CLINICAL FINDINGS
Authors: IMBRIACO M FURHANG EE HUMM JL YEUNG H ELSHIRBINI A ROBBINS R LARSON SM
Citation: M. Imbriaco et al., RADIATION-DOSE TO THE SALIVARY-GLANDS DURING I-131 TREATMENT OF THYROID-CANCER - CORRELATION WITH CLINICAL FINDINGS, The Journal of nuclear medicine, 38(5), 1997, pp. 978-978
PHARMACOKINETICS AND DOSIMETRY OF AN ALPHA-PARTICLE EMITTER LABELED ANTI-CD33 ANTIBODY ([213BI]HUM195) IN PATIENTS WITH LEUKEMIA
Authors: SGOUROS G ERDI YE HUMM JL MEHTA B MCDEVITT MR FINN RD JURCIC JG LARSON SM SCHEINBERG DA
Citation: G. Sgouros et al., PHARMACOKINETICS AND DOSIMETRY OF AN ALPHA-PARTICLE EMITTER LABELED ANTI-CD33 ANTIBODY ([213BI]HUM195) IN PATIENTS WITH LEUKEMIA, The Journal of nuclear medicine, 38(5), 1997, pp. 979-979
MULTIMODALITY BRAIN IMAGE REGISTRATION USING A 3-D PHOTOGRAMMETRICALLY DERIVED SURFACE
Authors: MAWLAWI OR BEATTIE BJ HUMM JL BLASBERG RG LARSON SM
Citation: Or. Mawlawi et al., MULTIMODALITY BRAIN IMAGE REGISTRATION USING A 3-D PHOTOGRAMMETRICALLY DERIVED SURFACE, The Journal of nuclear medicine, 38(5), 1997, pp. 1320-1320
SEGMENTATION OF LUNG LESION VOLUME BY ADAPTIVE POSITRON-EMISSION-TOMOGRAPHY IMAGE THRESHOLDING
Authors: ERDI YE MAWLAWI O LARSON SM IMBRIACO M YEUNG H FINN R HUMM JL
Citation: Ye. Erdi et al., SEGMENTATION OF LUNG LESION VOLUME BY ADAPTIVE POSITRON-EMISSION-TOMOGRAPHY IMAGE THRESHOLDING, Cancer, 80(12), 1997, pp. 2505-2509
TARGETED ALPHA-PARTICLE THERAPY FOR MYELOID LEUKEMIAS - A PHASE-I TRIAL OF BISMUTH-213-HUM195 (ANTI-CD33)
Authors: JURCIC JG MCDEVITT MR SGOUROS G BALLANGRUD A FINN RD GEERLINGS MW HUMM JL MOLINET R APOSTOLIDIS C LARSON SM SCHEINBERG DA
Citation: Jg. Jurcic et al., TARGETED ALPHA-PARTICLE THERAPY FOR MYELOID LEUKEMIAS - A PHASE-I TRIAL OF BISMUTH-213-HUM195 (ANTI-CD33), Blood, 90(10), 1997, pp. 2245-2245
ABSORBED DOSE TO THE SALIVARY-GLANDS IN THYROID PATIENTS UNDERGOING TREATMENT WITH I-131
Authors: ELSHIRBINY A IMBRIACO M YEUNG H FURHANG EE HUMM JL YEH SDJ ODONOGHUE JA MACAPINLAC H ROBBINS R LARSON SM
Citation: A. Elshirbiny et al., ABSORBED DOSE TO THE SALIVARY-GLANDS IN THYROID PATIENTS UNDERGOING TREATMENT WITH I-131, The Journal of nuclear medicine, 37(5), 1996, pp. 399-399
Risultati: 1-25 | 26-46